Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO
· Real-Time Price · USD
1.98
-0.06 (-2.94%)
At close: Aug 15, 2025, 3:59 PM
2.02
2.28%
After-hours: Aug 15, 2025, 07:41 PM EDT
Aptevo Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 902K | n/a | n/a | n/a | -3.11M | n/a | n/a | 3.11M | 3.67M | 3.1M | 3.11M | 2.42M |
Cost of Revenue | 49K | 61K | 71K | 54K | 91K | 106K | 116K | 123K | 150K | 178K | 161K | 222K | 3.87M | 242K | 4.54M | 4.37M | 4.72M | 5.36M |
Gross Profit | -49K | -61K | -71K | -54K | 106K | -106K | 786K | -123K | -150K | -178K | -3.27M | -222K | -3.87M | 2.87M | -878K | -1.27M | -1.61M | -2.94M |
Operating Income | -6.23M | -6.48M | -6.38M | -5.21M | -6.02M | -6.98M | -6.38M | -6.56M | -8.18M | -7.76M | -7.68M | -7.78M | -7.56M | -5.61M | -4.04M | -4.75M | -5.72M | -6.89M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -6.2M | -6.41M | -6.31M | -5.1M | -5.88M | -6.83M | -6.2M | -6.33M | -7.95M | 1.83M | -5.16M | -7.81M | 27.86M | -7.88M | -6.6M | -7.08M | -8.06M | -7.67M |
Net Income | -6.2M | -6.41M | -6.31M | -5.1M | -5.88M | -6.83M | -5.9M | -6.33M | -7.95M | 11.41M | 30.35M | -7.67M | 28.01M | -9.96M | -6.27M | -7M | -7.93M | -7.26M |
Selling & General & Admin | 2.9M | 2.85M | 2.5M | 2.11M | 2.38M | 3.23M | 2.79M | 2.67M | 2.72M | 3.59M | 3.01M | 3.31M | 3.7M | 3.86M | 3.16M | 3.48M | 4.11M | 3.95M |
Research & Development | 3.33M | 3.63M | 3.88M | 3.1M | 3.64M | 3.65M | 3.48M | 3.89M | 5.46M | 4.17M | 4.67M | 4.48M | 3.87M | 4.87M | 4.54M | 4.37M | 4.72M | 5.36M |
Other Expenses | n/a | -71K | -71K | n/a | n/a | n/a | n/a | 227K | 230K | -67K | 2.52M | -25K | 35.42M | -2.26M | -2.56M | -2.33M | -2.34M | -782K |
Operating Expenses | 6.23M | 6.41M | 6.31M | 5.21M | 5.93M | 6.88M | 6.27M | 6.56M | 8.18M | 7.76M | 7.68M | 7.78M | 7.56M | 8.72M | 7.71M | 7.85M | 8.83M | 9.31M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 9.58M | n/a | n/a | n/a | n/a | 25K | n/a | 2.26M | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.23M | 6.48M | 6.38M | 5.21M | 6.02M | 6.98M | 6.38M | 6.56M | 8.18M | 7.76M | 7.68M | 7.78M | 7.56M | 8.72M | 7.71M | 7.85M | 8.83M | 9.31M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 62.72K | n/a | n/a | 27.91K | -9.58M | -35.52M | n/a | -149K | 2.09M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 738.15K | 72.92K | 72.92K | 14.25K | 4.76K | 928.02 | 597.92 | 386.33 | 199.08 | 215.67 | 198.60 | 156.34 | 154.28 | 151.64 | 150.43 | 150.24 | 139.33 | 135.70 |
Shares Outstanding (Diluted) | 738.15K | 72.92K | 72.92K | 14.25K | 4.76K | 928.02 | 597.92 | 386.33 | 199.08 | 215.67 | 198.60 | 156.34 | 154.28 | 151.64 | 150.43 | 150.24 | 139.33 | 135.70 |
EPS (Basic) | -8.4 | -87.87 | -86.56 | -357.85 | -1.24K | -7.36K | -9.87K | -16.39K | -39.92K | 12.86K | -23.37K | -48.89K | 181.55K | -50.76K | -41.69K | -46.57K | -56.93K | -53.47K |
EPS (Diluted) | -8.4 | -87.87 | -86.56 | -357.85 | -1.24K | -7.36K | -9.87K | -16.39K | -39.92K | 12.86K | -23.37K | -48.89K | 181.55K | -50.76K | -41.69K | -46.57K | -56.93K | -53.47K |
EBITDA | -6.18M | -6.48M | -6.31M | -5.13M | -5.93M | -6.88M | -6.27M | -6.44M | -8.03M | -7.58M | -7.52M | -7.56M | -7.29M | -5.37M | -3.78M | -4.46M | -5.42M | -6.59M |
EBIT | -6.23M | -6.41M | -6.38M | -5.21M | -6.02M | -6.98M | -6.38M | -6.56M | -8.18M | -7.76M | -7.68M | -7.78M | -7.56M | -5.61M | -4.04M | -4.75M | -5.72M | -6.89M |
Depreciation & Amortization | 49K | 61K | 71K | 84K | 91K | 106K | 116K | 123K | 150K | 178K | 161K | 222K | 276K | 242K | 260K | 296K | 299K | 289K |